This is a longitudinal observational study on patients with gastrointestinal and related disease. The study will be conducted for at least 10 years, following each participant over time, as they either go through relapses and remissions, or progression of their disease.
This is a longitudinal, observational study whose main goal is to identify the human and microbial determinants of gastrointestinal diseases. Molecular and metadata will be collected from a large study population at multiple time points. Machine learning will be applied to all data, and models will be evaluated for development of novel diagnostic and therapeutic tools.
Study Type
OBSERVATIONAL
Enrollment
17
Viome Life Sciences
Bothell, Washington, United States
Identification of human determinants of gastrointestinal diseases.
Identification of biomarkers that indicate gastrointestinal diseases.
Time frame: Up to 10 years
Identification of microbial determinants of gastrointestinal diseases.
Identification of microbial species that indicate gastrointestinal disease.
Time frame: Up to 10 years
Prediction of efficacy of biologics in treating IBD.
Prediction of the efficacy of a biologic medication against IBD based on molecular data and metadata.
Time frame: Up to 10 years.
Development of a molecular test for C. difficile infection (CDI)
Development of a molecular test for C. difficile infection (CDI)
Time frame: Up to 10 years.
Quantify change in microbial species over time post colonoscopy
Quantification of changes observed in the microbiome post colonoscopy.
Time frame: Up to 10 years.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.